Pioglitazone Reduces Neointima Volume After Coronary Stent Implantation
- 1 November 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 112 (18) , 2792-2798
- https://doi.org/10.1161/circulationaha.105.535484
Abstract
Background— Restenosis requiring reintervention limits the long-term success after coronary stent implantation. Thiazolidinediones, like pioglitazone or rosiglitazone, are oral antidiabetic drugs w...Keywords
This publication has 21 references indexed in Scilit:
- Peroxisome Proliferator-Activated Receptors and AtherogenesisCirculation Research, 2004
- Rosiglitazone Facilitates Angiogenic Progenitor Cell Differentiation Toward Endothelial LineageCirculation, 2004
- Myocardial factor for timing of surgery in asymptomatic patients with mitral regurgitationAmerican Heart Journal, 2003
- Intracoronary β-Irradiation With a Rhenium-188–Filled Balloon CatheterCirculation, 2003
- Reduction of Major Adverse Cardiac Events With Intracoronary Compared With Intravenous Bolus Application of Abciximab in Patients With Acute Myocardial Infarction or Unstable Angina Undergoing Coronary AngioplastyCirculation, 2003
- Coronary in-stent restenosis—predictors, treatment and preventionEuropean Heart Journal, 2000
- Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non–insulin dependent diabetes mellitusJournal of the American College of Cardiology, 2000
- Long-Term Treatment with a Platelet Glycoprotein-Receptor Antagonist after Percutaneous Coronary RevascularizationNew England Journal of Medicine, 2000
- PPARγ-Ligands Inhibit Migration Mediated by Multiple Chemoattractants in Vascular Smooth Muscle CellsJournal of Cardiovascular Pharmacology, 1999
- Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1988